Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Phio Pharmaceuticals Corp. (PHIO) had Normalized Income after Taxes of $-2.37M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-2.37M |
|
-- |
|
-- |
|
$2.53M |
|
$-2.53M |
|
$0.16M |
|
$-2.37M |
|
$-2.37M |
|
$-2.37M |
|
$-2.37M |
|
$-2.37M |
|
|
Normalized Income after Taxes |
$-2.37M |
$-2.53M |
|
$-2.53M |
|
5.98M |
|
5.98M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$21.48M |
|
$0.01M |
|
$0.01M |
|
$21.49M |
|
$1.34M |
|
-- |
|
-- |
|
$1.34M |
|
$20.15M |
|
$20.15M |
|
$20.15M |
|
11.62M |
|
| Cash Flow Statement Financials | |
$-7.98M |
|
$-0.01M |
|
$23.64M |
|
$5.38M |
|
$21.03M |
|
$15.65M |
|
$0.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
16.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.99M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.77% |
|
-11.77% |
|
-11.03% |
|
-11.77% |
|
$1.73 |
|
$-1.34 |
|
$-1.33 |
|